Responding to the Scottish Breast Screening Programme Statistics published today by ISD Scotland, James Jopling, Interim Director for Breakthrough Breast Cancer in Scotland said
Landmark breast cancer study
Today sees some important new results published in Nature, from a study that has been carried out by Cancer Research UK.
Landmark breast cancer study
Today sees some important new results published in Nature, from a study that has been carried out by Cancer Research UK.
Response to draft NICE guidance on bevacizumab (Avastin)
Response to NICE?s decision to open a consultation on new, draft guidance which does not recommend bevacizumab for the first-time treatment of metastatic breast cancer, when used in combination with the chemotherapy drug, capecitabine.
Gene linked to breast cancer risk in younger women
Scientists have found the first direct link between breast cancer risk and genetically-determined levels of the hormone oestrogen in younger women, according to a paper published online in the Journal of the National Cancer Institute.
Blood test that could catch recurring breast cancer a year early
Breakthrough Breast Cancer responds to research presented at the 243rd National Meeting & Exposition of the American Chemical Society about a blood test which could catch recurring breast cancer a year early.
Blood test that could catch recurring breast cancer a year early
Breakthrough Breast Cancer responds to research presented at the 243rd National Meeting & Exposition of the American Chemical Society about a blood test which could catch recurring breast cancer a year early.
Workers bridge the gap
Unions get behind Breakthrough
Breakthrough health projects win thousands
Our health projects win hundreds of thousands in government grants
Woman’s Hour Debate
Breakthrough Breast Cancer?s Director of Policy and Campaigns Maggie Alexander appeared on Woman?s Hour (BBC Radio Four) to take part in a panel discussion following the release of Pink Ribbons Inc